Return of Benefit to Society of Publicly Funded Innovations to Combat COVID-19
In response to the COVID-19 pandemic, significant public funds have been invested worldwide into the research, development, and manufacturing of pharmaceutical products to combat the novel coronavirus. Traditionally, intellectual property (IP) rights have been justified in the pharmaceutical sector...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
SAGE Publishing
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/3c325e7f15c64ba1b3d4d978dde48b92 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|